Showing results (41-50 of 71) with videos related to
Sort By:
Pageof 8
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|August 1, 1995
Modelling the relative metabolic occurrence of alkyl-nitrogen bond cleavage using structure-reactivity mapsE M Gifford, M A Johnson, D G Kaiser, et al.The American Journal of Cardiology|October 1, 1995
Recurrence of primary (AL) amyloidosis in a transplanted heart with four-year survivalS Dubrey, R W Simms, M Skinner, et al.The American Journal of Cardiology|September 12, 2000
Positive atrial inotropic effect of dofetilide after cardioversion of atrial fibrillation or flutterJ M DeCara, A Pollak, S Dubrey, et al.Critical Care Medicine|October 1, 1983
External noninvasive cardiac pacing in out-of-hospital cardiac arrestR H Falk, L Jacobs, A Sinclair, et al.Journal of the American College of Cardiology|February 1, 1997
Intravenous dofetilide, a class III antiarrhythmic agent, for the termination of sustained atrial fibrillation or flutter. Intravenous Dofetilide InvestigatorsR H Falk, A Pollak, S N Singh, et al.The Journal of Infectious Diseases|August 1, 1976
Rapid intravenous injection of tobramycin: suggested dosage schedule and concentrations in serumA P Gillett, R H Falk, J Andrews, et al.Heart (British Cardiac Society)|July 1, 1997
Familial and primary (AL) cardiac amyloidosis: echocardiographically similar diseases with distinctly different clinical outcomesS W Dubrey, K Cha, M Skinner, et al.The American Journal of Cardiology|November 14, 1997
Features and prognosis of exertional syncope in light-chain associated AL cardiac amyloidosisB Chamarthi, S W Dubrey, K Cha, et al.Pacing and Clinical Electrophysiology : PACE|May 1, 1987
Cardiac activation during external cardiac pacingR H Falk, S T Ngai, D J Kumaki, et al.Journal of the American College of Cardiology|October 8, 1997
Electrophysiologic abnormalities in AL (primary) amyloidosis with cardiac involvementJ Reisinger, S W Dubrey, M Lavalley, et al.Pageof 8